{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:19:32Z","timestamp":1773393572505,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T00:00:00Z","timestamp":1673740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/15165\u20132"],"award-info":[{"award-number":["2012\/15165\u20132"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/05739\u20130"],"award-info":[{"award-number":["2019\/05739\u20130"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/11244\u20134"],"award-info":[{"award-number":["2019\/11244\u20134"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.biopha.2023.114263","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T17:44:06Z","timestamp":1673891046000},"page":"114263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A phytotherapic blend immunity-6\u2122 inhibits myeloid leukemic cells 2 activation involving purinergic signaling"],"prefix":"10.1016","volume":"159","author":[{"given":"Yanesko Fernandes","family":"Bella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Rocha","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Roberto","family":"Mateus-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysa Alves Rodrigues","family":"Brandao-Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamei","family":"Silva-Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana de Melo Batista","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regiane","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Alvaro Brandao","family":"Lopes-Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Vicente Franco","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo P.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.114263_bib1","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.4103\/0975-7406.155895","article-title":"Naturally occurring products in cancer therapy","volume":"7","author":"Rajesh","year":"2015","journal-title":"J. Pharm. bioallied Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11157-012-9303-x","article-title":"Plants as potential sources of natural immunomodulators","volume":"13","author":"Shukla","year":"2014","journal-title":"Rev. Environ. Sci. Bio\/Technol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib3","article-title":"Role of phytochemicals as immunomodulatory agents: a review","volume":"10","author":"Brindha","year":"2016","journal-title":"Int. J. Green. Pharm. (IJGP)"},{"issue":"8","key":"10.1016\/j.biopha.2023.114263_bib4","first-page":"556","article-title":"Antileukemia activity from root cultures of Vernonia amygdalina","volume":"3","author":"Khalafalla","year":"2009","journal-title":"J. Med. Plants Res."},{"key":"10.1016\/j.biopha.2023.114263_bib5","series-title":"Natural products for treatment of chronic myeloid leukemia. Anti-cancer drugsnature, synthesis and cell","first-page":"1","author":"Khajapeer","year":"2016"},{"issue":"15","key":"10.1016\/j.biopha.2023.114263_bib6","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.3390\/ijms20153618","article-title":"Yeast-derived \u03b2-glucan in cancer: novel uses of a traditional therapeutic","volume":"20","author":"Geller","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114263_bib7","series-title":"Green Tea Polyphenols","first-page":"19","article-title":"Biochemical and physicochemical characteristics of green tea polyphenols","author":"Tanaka","year":"2013"},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mam.2011.10.001","article-title":"Green tea EGCG, T cells, and T cell-mediated autoimmune diseases","volume":"33","author":"Wu","year":"2012","journal-title":"Mol. Asp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.114263_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11130-013-0354-0","article-title":"Correlation between catechin content and NF-\u03baB inhibition by infusions of green and black tea","volume":"68","author":"Di Lorenzo","year":"2013","journal-title":"Plant Foods Hum. Nutr."},{"issue":"11","key":"10.1016\/j.biopha.2023.114263_bib10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.intimp.2010.08.012","article-title":"Neutrophils: Cinderella of innate immune system","volume":"10","author":"Kumar","year":"2010","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-018-3960-y","article-title":"Antioxidant and anticancer activities of chamomile (Matricaria recutita L.)","volume":"12","author":"Al-Dabbagh","year":"2019","journal-title":"BMC Res. Notes"},{"issue":"5","key":"10.1016\/j.biopha.2023.114263_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST20180169","article-title":"Vitamin C and immune cell function in inflammation and cancer","volume":"46","author":"Ang","year":"2018","journal-title":"Biochem. Soc. Trans."},{"issue":"11","key":"10.1016\/j.biopha.2023.114263_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/nu9111211","article-title":"Vitamin C and immune function","volume":"9","author":"Carr","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.nu.06.070186.002053","article-title":"The biochemical functions of ascorbic acid","volume":"6","author":"Englard","year":"1986","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.biopha.2023.114263_bib15","doi-asserted-by":"crossref","DOI":"10.3816\/CLM.2009.s.035","article-title":"The use of new and better antibiotics for bacterial infections in patients with leukemia","volume":"9","author":"Rolston","year":"2009","journal-title":"Clin. Lymphoma Myeloma"},{"issue":"3","key":"10.1016\/j.biopha.2023.114263_bib16","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1097\/MPH.0000000000000792","article-title":"Bacterial infections in children with acute myeloid leukemia receiving ciprofloxacin prophylaxis","volume":"39","author":"Al Omar","year":"2017","journal-title":"J. Pediatr. Hematol. \/Oncol."},{"issue":"13","key":"10.1016\/j.biopha.2023.114263_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2217\/epi-2019-0052","article-title":"DNA methylation and the hygiene hypothesis: connecting respiratory allergy and childhood acute lymphoblastic leukemia","volume":"11","author":"Langie","year":"2019","journal-title":"Epigenomics"},{"issue":"10","key":"10.1016\/j.biopha.2023.114263_bib18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1055-9965.EPI-17-0584","article-title":"Allergies and childhood acute lymphoblastic leukemia: a case\u2013control study and meta-analysis","volume":"27","author":"Wallace","year":"2018","journal-title":"Cancer Epidemiol. Prev. Biomark."},{"key":"10.1016\/j.biopha.2023.114263_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0963-9969(00)00156-3","article-title":"Determination of flavonols in green and black tea leaves and green tea infusions by high-performance liquid chromatography","volume":"34","author":"Wang","year":"2001","journal-title":"Food Res. Int."},{"issue":"7","key":"10.1016\/j.biopha.2023.114263_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2007-971643","article-title":"Reversed-phase high-performance liquid chromatography analysis of apigenin and its glucosides in flowers of Matricaria chamomilla and chamomile extracts","volume":"42","author":"Redaelli","year":"1981","journal-title":"Planta Med."},{"issue":"3","key":"10.1016\/j.biopha.2023.114263_bib21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/molecules27030782","article-title":"MiodesinTM positively modulates the immune response in endometrial and vaginal cells","volume":"27","author":"Oliveira","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.114263_bib22","first-page":"36","article-title":"Aerobic exercise inhibits acute lung injury: from mouse to human evidence Exercise reduced lung injury markers in mouse and in cells","volume":"24","author":"Rigonato-Oliveira","year":"2018","journal-title":"Exerc Immunol. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2023.114263_bib23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/eji.201847657","article-title":"Creatine supplementation impairs airway inflammation in an experimental model of asthma involving P2\u00d77 receptor","volume":"49","author":"Garcia","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114263_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5507\/bp.2012.108","article-title":"The role of cytokines in acute myeloid leukemia: a systematic review","volume":"156","author":"Kupsa","year":"2012","journal-title":"Biomed. Pap. Med Fac. Univ. Palacky. Olomouc Czech Repub."},{"issue":"12","key":"10.1016\/j.biopha.2023.114263_bib25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/jir.1998.18.1045","article-title":"Differential regulation of interleukin-1alpha and interleukin-1beta in K-562 cells","volume":"18","author":"Ichiki","year":"1998","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imr.12615","article-title":"Function and regulation of IL-1\u03b1 in inflammatory diseases and cancer","volume":"281","author":"Malik","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2023.114263_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-11-87","article-title":"IL-1\u03b2 promotes stemness and invasiveness of colon cancer cells through Zeb1 activation","volume":"11","author":"Li","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2023.114263_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2407-11-130","article-title":"Inflammatory mediators in breast cancer: coordinated expression of TNF\u03b1 & IL-1\u03b2 with CCL2 & CCL5 and effects on epithelialto-mesenchymal transition","volume":"11","author":"Soria","year":"2011","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2023.114263_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ncb3346","article-title":"Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal","volume":"18","author":"Pietras","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.biopha.2023.114263_bib30","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.4049\/jimmunol.175.12.8200","article-title":"CD11b+\/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells","volume":"175","author":"Song","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114263_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cytogfr.2012.04.001","article-title":"Plasticity and cross-talk of interleukin 6-type cytokines","volume":"23","author":"Garbers","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.biopha.2023.114263_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharm. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2023.114263_bib34","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/14728222.2013.830105","article-title":"gp130: a promising drug target for cancer therapy","volume":"17","author":"Xu","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.biopha.2023.114263_bib35","article-title":"Targeting the tumor microenvironment: JAK-STAT3 signaling","volume":"2","author":"Bournazou","year":"2013","journal-title":"JAKSTAT"},{"issue":"3","key":"10.1016\/j.biopha.2023.114263_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"issue":"3","key":"10.1016\/j.biopha.2023.114263_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.191.1.89","article-title":"Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype","volume":"191","author":"K\u00f6rner","year":"2000","journal-title":"J. Exp. Med."},{"issue":"6917","key":"10.1016\/j.biopha.2023.114263_bib39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2023.114263_bib40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114263_bib41","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1182\/blood.V100.4.1215.h81602001215_1215_1219","article-title":"The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia","volume":"100","author":"Ferrajoli","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib42","article-title":"Serum level of TNF-alpha in patients with chronic myeloid leukemia on Imatinib therapy","volume":"22","author":"Zbaar","year":"2017","journal-title":"Med. J. Tikrit Univ."},{"issue":"5","key":"10.1016\/j.biopha.2023.114263_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer.","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2023.114263_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin Immunol."},{"key":"10.1016\/j.biopha.2023.114263_bib45","first-page":"21","article-title":"The interleukin-1 family","author":"Yazdi","year":"2016","journal-title":"Regul. Cytokine gene Expr. Immun. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2023.114263_bib46","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1182\/blood.V78.6.1476.1476","article-title":"Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity","volume":"78","author":"Estrov","year":"1991","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.biopha.2023.114263_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/JCI114622","article-title":"Biological properties of recombinant human monocytederived interleukin 1 receptor antagonist.","volume":"85","author":"Arend","year":"1990","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.biopha.2023.114263_bib48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/gtmb.2014.0011","article-title":"Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-\u03b21, IFN-\u03b3, and TNF-\u03b1 genes in chronic phase chronic myeloid leukemia","volume":"18","author":"Pehlivan","year":"2014","journal-title":"Genet Test. Mol. Biomark."},{"issue":"5","key":"10.1016\/j.biopha.2023.114263_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.bmt.1700902","article-title":"High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation","volume":"20","author":"Hempel","year":"1997","journal-title":"Bone Marrow Transpl."},{"issue":"5","key":"10.1016\/j.biopha.2023.114263_bib50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00008390-200209000-00008","article-title":"Interleukin-10, interleukin-6 and interferon-\u03b3 gene polymorphisms in melanoma patients","volume":"12","author":"Martinez-Escribano","year":"2002","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.114263_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1744-313X.2005.00502.x","article-title":"Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia","volume":"32","author":"Amirzargar","year":"2005","journal-title":"Int. J. Immunogenet."},{"issue":"4","key":"10.1016\/j.biopha.2023.114263_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0925-5710(97)00070-4","article-title":"Interleukin-10 inhibits the autocrine growth of leukemic blast cells from patients with acute myeloblastic leukemia","volume":"66","author":"Asano","year":"1997","journal-title":"Int J. Hematol."},{"issue":"7","key":"10.1016\/j.biopha.2023.114263_bib53","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.23785","article-title":"The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"issue":"9\u201310","key":"10.1016\/j.biopha.2023.114263_bib54","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0753-3322(01)00140-8","article-title":"Cytokine deregulation in cancer","volume":"55","author":"Kurzrock","year":"2001","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2023.114263_bib55","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","article-title":"IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.biopha.2023.114263_bib56","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1152\/ajpendo.00074.2003","article-title":"IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans","volume":"285","author":"Steensberg","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2023.114263_bib57","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","article-title":"Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels","volume":"61","author":"Sanchez-Correa","year":"2013","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib58","first-page":"3","article-title":"Changes in expression of klotho affect physiological processes, diseases, and cancer","volume":"21","author":"Xuan","year":"2018","journal-title":"Iran. J. Basic Med Sci."},{"key":"10.1016\/j.biopha.2023.114263_bib59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/bs.vh.2016.02.003","article-title":"Klotho-dependent cellular transport regulation","volume":"101","author":"Sopjani","year":"2016","journal-title":"Vitam. Horm."},{"issue":"3","key":"10.1016\/j.biopha.2023.114263_bib60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10799893.2016.1247862","article-title":"Regulation of dendritic cell function by insulin\/IGF1\/PI3K\/Akt signaling through klotho expression","volume":"37","author":"Xuan","year":"2017","journal-title":"J. Recept Signal Transduct. Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.114263_bib61","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10549-011-1824-4","article-title":"Epigenetic silencing of the tumor suppressor klotho in human breast cancer","volume":"133","author":"Rubinek","year":"2012","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.biopha.2023.114263_bib62","first-page":"111","article-title":"Klotho is silenced through promoter hypermethylation in gastric cancer","volume":"1","author":"Wang","year":"2011","journal-title":"Am. J. Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.114263_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13402-012-0118-0","article-title":"Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells","volume":"36","author":"Shu","year":"2013","journal-title":"Cell Oncol. (Dordr. )"},{"issue":"4","key":"10.1016\/j.biopha.2023.114263_bib64","doi-asserted-by":"crossref","DOI":"10.1159\/000235686","article-title":"KLOTHO gene polymorphisms G-395A and C1818T are associated with low-density lipoprotein cholesterol and uric acid in Japanese hemodialysis patients","volume":"30","author":"Shimoyama","year":"2009","journal-title":"Am. J. Nephrol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223000513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223000513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:54:31Z","timestamp":1773388471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223000513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":64,"alternative-id":["S0753332223000513"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114263","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phytotherapic blend immunity-6\u2122 inhibits myeloid leukemic cells 2 activation involving purinergic signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114263"}}